Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases
Authors:
- Kuang-Hui YuKYKuang-Hui Yu
- Chang-Fu KuoCKChang-Fu Kuo
- Lu Hsiang HuangLHLu Hsiang Huang
- Wen-Kuan HuangWHWen-Kuan Huang
- Lai-Chu SeeLSLai-Chu See
Open Access
- 1 May 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (18) , e3540
Abstract
The aim of this study was to determine whether inflammation is related to cancer development, and whether the incidence of cancer is increased and occurs in a site-specific manner in patients with systemic autoimmune rheumatic diseases (SARDs). This study included a nationwide dynamic cohort of patients with various newly diagnosed SARDs from 1997 to 2010 with follow-up until 2012. This study included 75,123 patients with SARDs. During 562,870 person-years of follow-up, 2844 patients developed cancer. Between 1997 and 2010, the highest number of newly diagnosed SARDs cases were rheumatoid arthritis (n = 35,182), followed by systemic lupus erythematosus (SLE, n = 15,623), Sjögren syndrome (n = 11,998), Kawasaki disease (n = 3469), inflammatory bowel disease (n = 2853), scleroderma (n = 1814), Behçet disease (n = 1620), dermatomyositis (n = 1119), polymyositis (n = 811), and vasculitis other than Kawasaki disease (n = 644). A significant standardized incidence ratio (SIR) of overall cancer was observed for patients with SLE (1.41; 95% confidence interval [CI], 1.28–1.56), Sjögren syndrome (1.19; 95% CI, 1.08–1.30), scleroderma (1.27; 95% CI, 1.02–1.59), dermatomyositis (4.79; 95% CI, 4.01–5.73), polymyositis (1.47; 95% CI, 1.05–2.06), vasculitis excluding Kawasaki disease (1.75; 95% CI, 1.20–2.55), and Kawasaki disease (2.88; 95% CI, 1.60–5.20). Overall, patients with most SARDs had a significantly higher risk of inflammation-associated site-specific cancers and hematologic malignancies. This study confirms that autoimmunity is associated with site-specific and hematological malignancies and provides clinical evidence of an association between inflammation and subsequent site-specific cancer development. These findings support the importance of inflammation in site-specific organ system carcinogenesis.Keywords
This publication has 28 references indexed in Scilit:
- Cancer risk in immune-mediated inflammatory diseases (IMID)Molecular Cancer, 2013
- Lung Cancer and Interstitial Lung Diseases: A Systematic ReviewPulmonary Medicine, 2012
- Malignancy as a comorbidity in rheumatic diseasesRheumatology, 2012
- Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population studyBritish Journal of Dermatology, 2011
- The prevention of infection-associated cancersCarcinogenesis, 2011
- Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veteransCancer, 2010
- Geoepidemiology of autoimmune rheumatic diseasesNature Reviews Rheumatology, 2010
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritisArthritis Research & Therapy, 2008
- Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973–1997European Journal of Epidemiology, 2007
- Rheumatoid arthritis and cancer riskEuropean Journal of Cancer, 1996